PDL-1 SP263 Ventana near me in New Delhi

PDL-1 SP263 Ventana is an immunohistochemistry (IHC) test used to assess the expression of programmed death-ligand 1 (PDL1) protein in tumor tissue samples. It utilizes the Ventana SP263 assay for assessing PD-L1 expression in various clinical settings. The test is commonly used to determine eligibility for immunotherapy treatment with pembrolizumab (Keytruda) in patients with non-small cell lung cancer (NSCLC) and urothelial carcinoma. It helps guide treatment decisions by identifying patients who are likely to benefit from PDL1-targeted immunotherapy.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.